Cabergoline
-
Molecular Structure
Detailed Description
IUPAC NAME-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-8g-ergoline-8-carboxamide
or
1-[(6-Allylergolin-8β-yl)-carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
MOLECULAR FORMULA-C26H37N5O2
MOLAR MASS-451.604 g/mol
hyperprolactinemia
adjunctive therapy of prolactin-producing pituitary gland tumors (prolactinomas);
monotherapy of Parkinson's disease in the early phase;
combination therapy, together with levodopa and a decarboxylase inhibitor such as carbidopa, in progressive-phase Parkinson's disease;
- Cabergoline